A dangerous drugs claim arises when a patient is harmed by a prescription medication that was defectively manufactured, carried a design that made it unreasonably dangerous, or was sold without an adequate warning about a risk the manufacturer knew or should have known about. Kentucky’s product liability statute, KRS 411.300, defines a product liability action broadly enough to reach harm caused by a drug’s formulation, testing, warning, or labeling, not just physical manufacturing defects.
Every prescription drug sold in the United States goes through the FDA’s New Drug Application process, which requires clinical trial data showing the drug’s benefits outweigh its known risks, but that approval reflects what was known at the time and does not guarantee every long-term or rare risk was identified before the drug reached patients. Kentucky law does create a presumption that a product was not defective if it complied with applicable government or FDA standards at the time it left the manufacturer’s control, but that presumption can be rebutted, and much of a dangerous drugs case is built around showing exactly why it should be.
Most patients assume that a serious side effect was simply an unfortunate but disclosed risk of the medication, and pharmaceutical manufacturers are rarely in a hurry to suggest otherwise. Once a pattern of serious adverse events connected to a drug begins to emerge, manufacturers and their legal teams typically start preparing their defense well before individual patients realize their own injury fits that pattern. By the time a patient connects a health complication to a medication they may have stopped taking months or years earlier, the specific prescription records and dosage history can already be difficult to reconstruct.
The steps taken after a dangerous drug injury directly affect the strength of the claim. Keep the medication’s packaging, prescription label, and any remaining pills if possible, and request your complete pharmacy and medical records documenting when you took the drug and for how long. Ask your prescribing physician whether your injury has been connected to the medication in the medical literature or in FDA safety communications. Report the adverse event through the FDA’s MedWatch program. Do not sign anything from the manufacturer’s representative, and do not assume a serious side effect was simply bad luck, before speaking with a dangerous drugs lawyer.
Do not assume your treating physician’s notes identify a dangerous medication as the cause of your injury. Physicians document symptoms and treatment, not whether a drug’s manufacturer failed to disclose a known risk. Forman & Associates issues preservation demands as soon as we are retained, securing pharmacy records, prescription history, manufacturer communications, and the drug’s FDA regulatory and adverse event history.
Dangerous drug injuries range from acute reactions that appear shortly after starting a medication to serious conditions, such as internal bleeding, organ damage, or cardiovascular events, that develop gradually and are easy to attribute to something else at first. Prompt, thorough medical evaluation and consistent follow-up care protect your health and create the medical record a dangerous drugs lawyer needs to connect your specific injury to the medication that caused it.
A thorough investigation goes well beyond a single patient’s prescription history. Our firm reviews the drug’s FDA approval history, any adverse event reports filed through the FDA’s MedWatch system, whether the drug has been the subject of a drug recall or a boxed warning added after approval, and whether the manufacturer knew or should have known about the risk that caused your injury. Under a legal principle known as the learned intermediary doctrine, a manufacturer’s duty to warn generally runs to the prescribing physician rather than directly to the patient, which makes what the manufacturer told doctors, and when, central to building the case.
At Forman & Associates, we take control of the investigation the moment we are retained. We identify the manufacturer and any other party in the chain of distribution who may share responsibility, build the medical and regulatory record needed to prove the drug was dangerous, and communicate directly with manufacturers and their insurers so our clients are not left navigating a complex, document-heavy process alone.
Certain blood thinners and heart medications have been linked to uncontrolled bleeding events and other serious cardiovascular complications when their risks were not adequately disclosed to patients and physicians.
Some medications used to manage diabetes have been associated with serious cardiac, kidney, or other organ complications that emerged only after years of widespread use.
Certain psychiatric medications carry risks, including severe withdrawal symptoms and increased risk of self-harm in specific populations, that require clear and adequate warnings to prescribing physicians and patients.
Opioid pain medications carry a well-documented risk of dependence, and manufacturers who understated that risk or aggressively marketed a medication beyond its safe use may bear responsibility for the resulting harm.
Certain hormone replacement and birth control medications have been linked to increased risk of blood clots, stroke, or certain cancers when those risks were not clearly communicated.
Specialty and chemotherapy drugs carry serious inherent risks, and manufacturers can still be held responsible when a drug's manufacturing defect or an undisclosed risk causes harm beyond what patients and physicians were told to expect.
Kentucky law entitles patients harmed by a dangerous prescription drug to pursue full compensation for every consequence of that injury, and the long-term health complications caused by dangerous medications often make these damages substantial.
In a Kentucky dangerous drugs lawsuit, recoverable damages typically include:
Future damages are the category most often undervalued when a patient assumes their claim ends with their current course of treatment. Our catastrophic injury and product liability teams work with medical experts to document the full forward-looking cost of a dangerous drug injury, and when the injury proves fatal, Kentucky law also allows the family to bring a separate wrongful death claim against the manufacturer.
Larry Forman has actually stood before juries and won. That track record is known in Kentucky legal circles — and it changes how the other side negotiates.
Pharmacy records, FDA adverse event reports, and manufacturer communications are time-sensitive. We issue preservation demands from the moment we take your case, before evidence can be lost or become harder to obtain.
The interaction between Kentucky's product liability statute, the FDA's drug approval framework, and a manufacturer's duty to warn prescribing physicians is not an abstract legal concept to our team. It is the framework we navigate for dangerous drugs clients every day.
From expert witness retention to pattern-of-misconduct research, we build cases designed to win at trial — not just settle quickly to move to the next file.
You pay nothing out of pocket. Our firm advances all costs, and we only collect if we secure a recovery on your behalf. Zero financial risk to you.
Larry Forman is one of the most-watched legal voices online. He knows how to tell your story — in front of a jury, a judge, or a national audience.
Over $5,000,000 recovered for injured people all over the United States.
Past results do not guarantee future outcomes. Each case is unique.
Yes, but the process is significantly more complex than suing a private party.
Kentucky law recognizes three main theories in a dangerous drugs case: a manufacturing defect, where a specific batch was not produced according to its own specifications, a design defect, where the drug's formulation creates an unreasonable risk, and a failure to warn, where the manufacturer did not adequately disclose a known risk to physicians or patients. A dangerous drugs lawyer investigates which of these theories fits your situation.
Government entities in Kentucky are protected by sovereign immunity, which means you must comply with specific notice requirements and procedural rules before a lawsuit can be filed. In some cases, you may have as little as 30 to 90 days from the date of the incident to file a formal notice of claim. Missing that deadline can permanently bar your case. An experienced attorney must be involved immediately.
Not necessarily. FDA approval reflects what was known about a drug's risks and benefits at the time it was reviewed, and manufacturers have an ongoing duty to update warnings as new risks become known after approval. A drug can still support a claim if the manufacturer failed to disclose a risk it knew about, whether that knowledge came before or after approval.
Yes, in some respects. Generic drug manufacturers are generally required to use the same labeling as the brand-name version of the drug, which affects certain types of claims against them. A dangerous drugs lawyer can explain how this distinction applies to your specific medication and situation.
Kentucky's general statute of limitations for personal injury claims is one year under KRS 413.140. Because drug-related injuries can develop gradually and are not always immediately connected to the medication, when that one-year period begins to run can be a complicated legal question. It is important to speak with a dangerous drugs lawyer as soon as you suspect a medication caused your injury.
Yes. A recall or an updated warning label does not automatically resolve an injured patient's legal claim, and pursuing your own case is generally necessary to recover compensation for your specific injury, medical expenses, and other losses.
Off-label prescribing, meaning use for a purpose not specifically approved by the FDA, is common and legal for physicians. However, if a manufacturer improperly promoted a drug for an off-label use without adequate warnings about the risks of that use, the manufacturer may still bear responsibility for resulting harm.
